STRIDE INC (LRN) Fundamental Analysis & Valuation

NYSE:LRN • US86333M1080

Current stock price

94.97 USD
-2.19 (-2.25%)
Last:

This LRN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. LRN Profitability Analysis

1.1 Basic Checks

  • In the past year LRN was profitable.
  • LRN had a positive operating cash flow in the past year.
  • Each year in the past 5 years LRN has been profitable.
  • In the past 5 years LRN always reported a positive cash flow from operatings.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.83%, LRN belongs to the top of the industry, outperforming 90.41% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 20.61%, LRN belongs to the top of the industry, outperforming 86.30% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 16.82%, LRN belongs to the top of the industry, outperforming 89.04% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for LRN is below the industry average of 15.24%.
  • The last Return On Invested Capital (16.82%) for LRN is above the 3 year average (11.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.83%
ROE 20.61%
ROIC 16.82%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • LRN has a better Profit Margin (12.66%) than 80.82% of its industry peers.
  • LRN's Profit Margin has improved in the last couple of years.
  • The Operating Margin of LRN (18.38%) is better than 79.45% of its industry peers.
  • LRN's Operating Margin has improved in the last couple of years.
  • LRN has a Gross Margin of 39.30%. This is comparable to the rest of the industry: LRN outperforms 42.47% of its industry peers.
  • LRN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.38%
PM (TTM) 12.66%
GM 39.3%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. LRN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LRN is creating value.
  • LRN has more shares outstanding than it did 1 year ago.
  • LRN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, LRN has an improved debt to assets ratio.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 6.36 indicates that LRN is not in any danger for bankruptcy at the moment.
  • LRN has a Altman-Z score of 6.36. This is amongst the best in the industry. LRN outperforms 93.15% of its industry peers.
  • The Debt to FCF ratio of LRN is 3.02, which is a good value as it means it would take LRN, 3.02 years of fcf income to pay off all of its debts.
  • LRN has a better Debt to FCF ratio (3.02) than 75.34% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that LRN is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.31, LRN perfoms like the industry average, outperforming 54.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.02
Altman-Z 6.36
ROIC/WACC2.04
WACC8.26%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

  • LRN has a Current Ratio of 7.27. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 7.27, LRN belongs to the best of the industry, outperforming 97.26% of the companies in the same industry.
  • LRN has a Quick Ratio of 7.19. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 7.19, LRN belongs to the best of the industry, outperforming 97.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.27
Quick Ratio 7.19
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LRN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.79% over the past year.
  • Measured over the past years, LRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 58.07% on average per year.
  • The Revenue has grown by 17.90% in the past year. This is quite good.
  • LRN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.24% yearly.
EPS 1Y (TTM)12.79%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%13.86%
Revenue 1Y (TTM)17.9%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%2.69%

3.2 Future

  • LRN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.78% yearly.
  • Based on estimates for the next years, LRN will show a small growth in Revenue. The Revenue will grow by 5.66% on average per year.
EPS Next Y22.73%
EPS Next 2Y14.4%
EPS Next 3Y12.78%
EPS Next 5YN/A
Revenue Next Year6.51%
Revenue Next 2Y5.62%
Revenue Next 3Y5.4%
Revenue Next 5Y5.66%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

7

4. LRN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.14, which indicates a correct valuation of LRN.
  • Based on the Price/Earnings ratio, LRN is valued a bit cheaper than 68.49% of the companies in the same industry.
  • LRN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.77.
  • LRN is valuated correctly with a Price/Forward Earnings ratio of 12.06.
  • Based on the Price/Forward Earnings ratio, LRN is valued cheaper than 80.82% of the companies in the same industry.
  • LRN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.75, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.14
Fwd PE 12.06
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 75.34% of the companies in the same industry are more expensive than LRN, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of LRN indicates a somewhat cheap valuation: LRN is cheaper than 65.75% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.54
EV/EBITDA 6.74
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • LRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of LRN may justify a higher PE ratio.
  • A more expensive valuation may be justified as LRN's earnings are expected to grow with 12.78% in the coming years.
PEG (NY)0.58
PEG (5Y)0.23
EPS Next 2Y14.4%
EPS Next 3Y12.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LRN Dividend Analysis

5.1 Amount

  • LRN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LRN Fundamentals: All Metrics, Ratios and Statistics

STRIDE INC

NYSE:LRN (5/1/2026, 10:27:48 AM)

94.97

-2.19 (-2.25%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Industry Strength9.32
Industry Growth63.35
Earnings (Last)04-28
Earnings (Next)08-03
Inst Owners110.38%
Inst Owner Change-1.11%
Ins Owners3.1%
Ins Owner Change-0.88%
Market Cap4.04B
Revenue(TTM)2.41B
Net Income(TTM)318.94M
Analysts84.44
Price Target135.79 (42.98%)
Short Float %16.45%
Short Ratio9.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.44%
Min EPS beat(2)18.86%
Max EPS beat(2)26.01%
EPS beat(4)2
Avg EPS beat(4)0.71%
Min EPS beat(4)-41.53%
Max EPS beat(4)26.01%
EPS beat(8)6
Avg EPS beat(8)44.91%
EPS beat(12)10
Avg EPS beat(12)45.21%
EPS beat(16)13
Avg EPS beat(16)17.55%
Revenue beat(2)1
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.46%
Max Revenue beat(2)0.16%
Revenue beat(4)3
Avg Revenue beat(4)1.49%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.34%
Revenue beat(8)7
Avg Revenue beat(8)2.32%
Revenue beat(12)10
Avg Revenue beat(12)2.47%
Revenue beat(16)14
Avg Revenue beat(16)2.55%
PT rev (1m)0%
PT rev (3m)0.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.25%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 13.14
Fwd PE 12.06
P/S 1.61
P/FCF 22.54
P/OCF 16.34
P/B 2.61
P/tB 3.53
EV/EBITDA 6.74
EPS(TTM)7.23
EY7.61%
EPS(NY)7.88
Fwd EY8.3%
FCF(TTM)4.21
FCFY4.44%
OCF(TTM)5.81
OCFY6.12%
SpS59.16
BVpS36.35
TBVpS26.93
PEG (NY)0.58
PEG (5Y)0.23
Graham Number76.899 (-19.03%)
Profitability
Industry RankSector Rank
ROA 13.83%
ROE 20.61%
ROCE 22.19%
ROIC 16.82%
ROICexc 24.03%
ROICexgc 33.13%
OM 18.38%
PM (TTM) 12.66%
GM 39.3%
FCFM 7.12%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
ROICexc(3y)20.97%
ROICexc(5y)16.99%
ROICexgc(3y)36.26%
ROICexgc(5y)30.39%
ROCE(3y)15.79%
ROCE(5y)13.55%
ROICexgc growth 3Y30.19%
ROICexgc growth 5Y48.22%
ROICexc growth 3Y36.36%
ROICexc growth 5Y54.51%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
F-Score7
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.02
Debt/EBITDA 0.83
Cap/Depr 57.06%
Cap/Sales 2.7%
Interest Coverage 44.37
Cash Conversion 42.51%
Profit Quality 56.26%
Current Ratio 7.27
Quick Ratio 7.19
Altman-Z 6.36
F-Score7
WACC8.26%
ROIC/WACC2.04
Cap/Depr(3y)56.69%
Cap/Depr(5y)59.43%
Cap/Sales(3y)3.07%
Cap/Sales(5y)3.32%
Profit Quality(3y)114.14%
Profit Quality(5y)117.4%
High Growth Momentum
Growth
EPS 1Y (TTM)12.79%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%13.86%
EPS Next Y22.73%
EPS Next 2Y14.4%
EPS Next 3Y12.78%
EPS Next 5YN/A
Revenue 1Y (TTM)17.9%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%2.69%
Revenue Next Year6.51%
Revenue Next 2Y5.62%
Revenue Next 3Y5.4%
Revenue Next 5Y5.66%
EBIT growth 1Y38.43%
EBIT growth 3Y38.88%
EBIT growth 5Y66.8%
EBIT Next Year37.23%
EBIT Next 3Y12.15%
EBIT Next 5Y18.08%
FCF growth 1Y13.3%
FCF growth 3Y38.85%
FCF growth 5Y60.14%
OCF growth 1Y12.51%
OCF growth 3Y27.9%
OCF growth 5Y40.03%

STRIDE INC / LRN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of STRIDE INC (LRN) stock?

ChartMill assigns a fundamental rating of 7 / 10 to LRN.


What is the valuation status of STRIDE INC (LRN) stock?

ChartMill assigns a valuation rating of 7 / 10 to STRIDE INC (LRN). This can be considered as Undervalued.


What is the profitability of LRN stock?

STRIDE INC (LRN) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for LRN stock?

The Price/Earnings (PE) ratio for STRIDE INC (LRN) is 13.14 and the Price/Book (PB) ratio is 2.61.


What is the financial health of STRIDE INC (LRN) stock?

The financial health rating of STRIDE INC (LRN) is 8 / 10.